Table 1 Clinical, radiological and physiological characteristics of the patients

N

287

Age (years)

64 ± 9

Follow up (months)

65 (36–100)

Gender (%) male/female

83/17

Pack-year (units)

51 ± 27

Current Smoker (%) yes/no

50/50

Framingham index (%)

27 (17–42)

SCORE index (%)

4 ± 3

Charlson (Units)

1 (1–2)

BMI (Kg/m2)

27.3 ± 4.8

FEV₁/FVC (%)

55 ± 11

FEV₁ (liters)

2.18 ± 0.8

FEV1%

70 ± 22

FVC %

99 ± 20

TLC %

106 ± 15

IC/TLC

0.33 ± 0.1

MMRC 0–4 (%)

36/32/21/9/2

6MWD (m)

465 ± 114

BODE Quart 1–4 (%)

82/10/5/3

Hypertension (%) yes/no

36/64

Anti-hypertensive treatment (%) yes/no

65/35

SBP (mmHg)

129 ± 19

DBP (mmHg)

76 ± 10.4

DM (%) yes/no

11/89

Glucose (mg/dL)

97 (90–108)

HbA1c %

5.9 (5.6–6.5)

Dyslipidemia (%) yes/no

71/29

Anti-hyperlipidemia treatment (%)yes/no

73/27

Total Cholesterol (mg/dL)

202 (172–232)

LDL-C (mg/dL)

124 (97.3–156)

HDL-C (mg/dL)

50 (41–61.8)

Urine Albumin/Creatinine ratio (mg/g)

12.8 (6–32.6)

EAT (cm³)

153 (112–211)

Coronary Calcium Score (Units)

2 (1–3)

CRP (mg/dL)

0.4 (0.2–0.8)

Systemic corticosteroid treatment (%) yes/no

6/94